Authors:
Lin, HS
Rampersaud, AA
Richett, ME
Harper, RW
Beavers, LS
McClure, DB
Gardner, AJ
Eacho, PI
Foxworthy, PS
Gadski, RA
Citation: Hs. Lin et al., Synthesis and in vitro biological activity of 4 alpha-(2-propenyl)-5 alpha-cholest-24-en-3 alpha-ol: A 24,25-dehydro analog of the hypocholesterolemic agent 4 alpha-(2-propenyl)-5 alpha-cholestan-3 alpha-ol, STEROIDS, 64(3), 1999, pp. 217-227
Authors:
Lin, HS
Rampersaud, AA
Beavers, LS
McClure, DB
Gardner, AJ
Eacho, PI
Foxworthy, PS
Gadski, RA
Citation: Hs. Lin et al., Synthesis and in vitro biological activity of 4 alpha-(2-propenyl)-5 alpha-cholest-24-en-3 alpha,12 alpha-diol, a 12 alpha-hydroxyl analog of 4 alpha-(2-propenyl)-5 alpha-cholest-24-en-3 alpha-ol: The latter is a potent activator of the low-density lipoprotein receptor promoter, STEROIDS, 64(10), 1999, pp. 735-741
Authors:
Bensch, WR
Gadski, RA
Bean, JS
Beavers, LS
Schmidt, RJ
Perry, DN
Murphy, AT
McClure, DB
Eacho, PI
Breau, AP
Archer, RA
Kauffman, RF
Citation: Wr. Bensch et al., Effects of LY295427, a low-density lipoprotein (LDL) receptor up-regulator, on LDL receptor gene transcription and cholesterol metabolism in normal and hypercholesterolemic hamsters, J PHARM EXP, 289(1), 1999, pp. 85-92